[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE247964T1 - Als inhibitoren der aicarftnützliche verbindungen - Google Patents

Als inhibitoren der aicarftnützliche verbindungen

Info

Publication number
ATE247964T1
ATE247964T1 AT99944088T AT99944088T ATE247964T1 AT E247964 T1 ATE247964 T1 AT E247964T1 AT 99944088 T AT99944088 T AT 99944088T AT 99944088 T AT99944088 T AT 99944088T AT E247964 T1 ATE247964 T1 AT E247964T1
Authority
AT
Austria
Prior art keywords
aicarft
inhibitors
compounds useful
compounds
useful
Prior art date
Application number
AT99944088T
Other languages
English (en)
Inventor
Ted Michael Bleckman
Cynthia Louise Palmer
William Henry Romines Iii
Michael David Varney
Original Assignee
Agouron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agouron Pharma filed Critical Agouron Pharma
Application granted granted Critical
Publication of ATE247964T1 publication Critical patent/ATE247964T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT99944088T 1998-09-04 1999-09-03 Als inhibitoren der aicarftnützliche verbindungen ATE247964T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9925998P 1998-09-04 1998-09-04
PCT/US1999/020331 WO2000013688A1 (en) 1998-09-04 1999-09-03 Compounds useful as aicarft inhibitors

Publications (1)

Publication Number Publication Date
ATE247964T1 true ATE247964T1 (de) 2003-09-15

Family

ID=22273984

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99944088T ATE247964T1 (de) 1998-09-04 1999-09-03 Als inhibitoren der aicarftnützliche verbindungen

Country Status (9)

Country Link
US (1) US6525050B1 (de)
EP (1) EP1109560B1 (de)
AT (1) ATE247964T1 (de)
AU (1) AU5705099A (de)
DE (1) DE69910799T2 (de)
DK (1) DK1109560T3 (de)
ES (1) ES2207277T3 (de)
PT (1) PT1109560E (de)
WO (1) WO2000013688A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6495558B1 (en) 1999-01-22 2002-12-17 Amgen Inc. Kinase inhibitors
US7279160B2 (en) * 2000-05-02 2007-10-09 The Uab Research Foundation Combinations of DR5 antibodies and other therapeutic agents
US7700307B2 (en) 2003-03-08 2010-04-20 Auvation Limited Mitochondrial stress-70 protein markers for colorectal cancer
US9077766B2 (en) 2004-07-09 2015-07-07 Qualcomm Incorporated System and method for combining memory resources for use on a personal network
US8819140B2 (en) 2004-07-09 2014-08-26 Qualcomm Incorporated System and method for enabling the establishment and use of a personal network
US8195744B2 (en) 2004-07-09 2012-06-05 Orb Networks, Inc. File sharing system for use with a network
US7937484B2 (en) 2004-07-09 2011-05-03 Orb Networks, Inc. System and method for remotely controlling network resources
US8738693B2 (en) 2004-07-09 2014-05-27 Qualcomm Incorporated System and method for managing distribution of media files
WO2006031806A2 (en) * 2004-09-10 2006-03-23 Atherogenics, Inc. 2-thiopyrimidinones as therapeutic agents
US20070015720A1 (en) * 2005-02-04 2007-01-18 Cytrx Corporation Modulation of endogenous AICAR levels for the treatment of diabetes and obesity
US8973072B2 (en) 2006-10-19 2015-03-03 Qualcomm Connected Experiences, Inc. System and method for programmatic link generation with media delivery
US8252804B2 (en) 2008-10-01 2012-08-28 Duquesne University Of The Holy Spirit Selective proton coupled folate transporter and folate receptor, and GARFTase inhibitor compounds and methods of using the same
US20110082158A1 (en) * 2008-10-01 2011-04-07 Aleem Gangjee Selective proton coupled folate transporter and folate receptor, and garftase and/or other folate metabolizing enzymes inhibitor compounds and methods of using the same
JP6379296B2 (ja) * 2014-12-02 2018-08-22 イーライ リリー アンド カンパニー １−オキソ−１，２−ジヒドロイソキノリン−７−イル−（５−置換−チオフェン−２−イル）−スルホンアミド化合物、それらの化合物を含む製剤、がん治療におけるａｉｃａｒｆｔ阻害剤としてのそれらの使用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU203736B (en) * 1989-04-06 1991-09-30 Gyogyszerkutato Intezet Process for producing new thiouracil-derivatives and pharmaceutical compositions containing them
CA2151588C (en) * 1992-12-16 2002-03-19 Michael D. Varney Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone
JP3401597B2 (ja) * 1993-01-08 2003-04-28 株式会社マンダム 皮膚保護剤組成物

Also Published As

Publication number Publication date
ES2207277T3 (es) 2004-05-16
DK1109560T3 (da) 2003-11-03
DE69910799D1 (de) 2003-10-02
EP1109560A1 (de) 2001-06-27
EP1109560B1 (de) 2003-08-27
EP1109560A4 (de) 2002-04-17
PT1109560E (pt) 2004-01-30
DE69910799T2 (de) 2004-02-19
WO2000013688A1 (en) 2000-03-16
US6525050B1 (en) 2003-02-25
AU5705099A (en) 2000-03-27

Similar Documents

Publication Publication Date Title
TR200201505T2 (tr) Terapötik maddeler olarak pirazolopirimidinler
UA84175C2 (ru) Гетероциклические ингибиторы мэк и их применение
NO20061506L (no) Heterocykliske inhibitorer av MEK og fremgangsmater for anvendelse derav
EA200500018A1 (ru) Бензконденсированные гетероариламидные производные тиенопиридинов, применяемые в качестве терапевтических агентов, фармацевтические композиции, включающие их, и способы их применения
DE60030741D1 (de) Chinazoline verbindungen als heilmittel
SE9504661D0 (sv) New compounds
NO20020925L (no) N-heterosykliske derivater av NOS-inhibitorer
CA2478374A1 (en) N3 alkylated benzimidazole derivatives as mek inhibitors
DK0738270T3 (da) Dihydropyrazolopyrroler
DE60103147D1 (de) 1,1-dioxoisothiazolidin-substituierte indazole als inhibitoren der zellproliferation
EA200500174A1 (ru) Новые производные бензимидазола, полезные в качестве антипролиферативных агентов
ATE252097T1 (de) N-heterocyclische derivate als nos inhibitoren
TR200103395T2 (tr) 13-metil eritromisin türevleri.
ATE247964T1 (de) Als inhibitoren der aicarftnützliche verbindungen
SE9802208D0 (sv) Novel compounds
ATE233754T1 (de) Diphenyl-piperidin derivate
SE9504662D0 (sv) New compounds
ATE250610T1 (de) Kaliumkanal-blockierende mittel
EA200200292A1 (ru) Производные гигромицина
ATE279113T1 (de) Hypoxanthin- und thiohypxanthin-verbindungen
SE0301698D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
ATE228359T1 (de) Hemmung der leukotrienbiosynthese mittels harnstoffderivaten
IL139317A0 (en) Benzimdazole and benzoxazole derivatives and pharmaceutical compositions contining the same
AR026285A1 (es) Profarmacos de higromicina a
HUP0202237A2 (hu) Amin, módosított pszeudomicin vegyületek, azokat tartalmazó gyógyászati készítmény és alkalmazásuk

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1109560

Country of ref document: EP

REN Ceased due to non-payment of the annual fee